검색어 : 통합검색[Cancer drug discovery and development]
총 10,586건 중 1,000건 출력
, 96/100 페이지
-
951
- Drug discovery and mutant p53
- Maslon, M.M.; Hupp, T.R.; University of Edinburgh, Institute of Genetics and Molecular Medicine, Cell Signalling Unit, CRUK p53 Signal Transduction Group, Edinburgh, EH4 2XR UK; (Trends in cell biology, v.20, 2010, pp.542-555)
-
952
- STING modulators: Predictive significance in drug discovery
- Cui, Xiangling; Zhang, Rongyu; Cen, Shan; Zhou, Jinming; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University; Institute of Medicinal Biotechnology, Chinese Academy of Medical Science; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University; (European journal of medicinal chemistry, v.182, 2019, pp.111591)
-
953
- Organelle Interaction and Drug Discovery: Towards Correlative Nanoscopy and Molecular Dynamics Simulation
- Yang, Zhiwei; Zhang, Zichen; Zhao, Yizhen; Ye, Qiushi; Li, Xuhua; Meng, Lingjie; Long, Jiangang; Zhang, Shengli; Zhang, Lei; MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter , School of Physics , Xi’an Jiaotong University , Xi’an , China; MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter , School of Physics , Xi’an Jiaotong University , Xi’an , China; MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter , School of Physics , Xi’an Jiaotong University , Xi’an , China; MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter , School of Physics , Xi’an Jiaotong University , Xi’an , China; MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter , School of Physics , Xi’an Jiaotong University , Xi’an , China; School of Chemistry , Xi’an Jiaotong University , Xi’an , China; School of; (Frontiers in pharmacology, v.13, 2022, pp.935898)
-
954
- Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
- Realini, Natalia; Solorzano, Carlos; Pagliuca, Chiara; Pizzirani, Daniela; Armirotti, Andrea; Luciani, Rosaria; Costi, Maria Paola; Bandiera, Tiziano; Piomelli, Daniele; Department of Anatomy and Neurobiology, University of California , Irvine, California 92697-4625; Department of Anatomy and Neurobiology, University of California , Irvine, California 92697-4625; Unit of Drug Discovery and Development, Italian Institute of Technology , Genoa, Italy 16163; Unit of Drug Discovery and Development, Italian Institute of Technology , Genoa, Italy 16163; Unit of Drug Discovery and Development, Italian Institute of Technology , Genoa, Italy 16163; Dipartimento di Scienze Farmaceutiche, University of Modena and Reggio Emilia , Modena, Italy 41125; Dipartimento di Scienze Farmaceutiche, University of Modena and Reggio Emilia , Modena, Italy 41125; Unit of Drug Discovery and Development, Italian Institute of Technology , Genoa, Italy 16163; Department of Anatomy and Neurobiology, University of California , Irvine, California 92697-4625; (Scientific reports, v.3, 2013, pp.1035)
-
955.
- Discovery of Cancer Biomarkers using Public EST and Microarray Data
- 신영아
- 이화여자대학교 대학원, 국내박사, ix, 162 p., 2008
-
956
- Development of a Cyanovirin-N-HIV-1 gpl20 Binding Assay for High Throughput Screening of Natural Product Extracts by Time-Resolved Fluorescence
- McMahon, James B.; Beutler, John A.; O'Keefe, Barry R.; Goodrum, Colby B.B.; Myers, Marc A.; Boyd, Michael R.; Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD; SAIC Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD; Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD; Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD; Laboratory of Drug Discovery Research and Development, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute-Frederick Cancer Research and Development Center,; (Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening, v.5, 2000, pp.169-176)
-
957
- Sleeping beauty: a novel cancer gene discovery tool
- Dupuy, Adam J.; Jenkins, Nancy A.; Copeland, Neal G.; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; To whom correspondence should be addressed. Tel: +1 3018461260; Fax: +1 3018466666; Email: copeland@ncifcrf.gov; (Human molecular genetics, v.15, 2006, pp.R75-R79)
-
958
- DrugComboRanker: drug combination discovery based on target network analysis
- Huang, Lei; Li, Fuhai; Sheng, Jianting; Xia, Xiaofeng; Ma, Jinwen; Zhan, Ming; Wong, Stephen T.C.; Department of Information Science, School of Mathematical Sciences and LMAM, Peking University, Beijing, 100871, China and NCI Center for Modeling Cancer Development, Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute; Weill Cornell Medical College of Cornell University, Houston, TX 77030, USA; Department of Information Science, School of Mathematical Sciences and LMAM, Peking University, Beijing, 100871, China and NCI Center for Modeling Cancer Development, Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute; Weill Cornell Medical College of Cornell University, Houston, TX 77030, USA; Department of Information Science, School of Mathematical Sciences and LMAM, Peking University, Beijing, 100871, China and NCI Center for Modeling Cancer Development, Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute; Weill Cornell Medical College of Cornell Universi; (Bioinformatics, v.30, 2014, pp.i228-i236)
-
959
- Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic
- Oo, Charles; Ameer, Barbara; Corresponding author.; (Drug discovery today, v.26, 2021, pp.1337-1339)
-
960
- Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors
- Bauer, Ludwig G.; Ward, Jennifer A.; Dí az‐ Sá ez, Laura; Sundströ m, Yvonne; Tolvanen, Tuomas; Alarcó n Barrera, Juan Carlos; Kostidis, Sarantos; Rogers, Catherine M.; Panagakou, Ioanna; Singh, Usha; Rothweiler, Elisabeth M.; Gonzalez Orta, Alejandro; Kaniskan, H. Ü mit; Hu, Jianping; Jin, Jian; Sievers, Sonja; Waldmann, Herbert; Giera, Martin; Sundströ m, Michael; Berg, Louise; Huber, Kilian V. M.; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Structural Genomics Consortium Karolinska Institutet 17176 Solna Sweden; Structural Genomics Consortium Karolinska Institutet 17176 Solna Sweden; Center for Proteomics and Metabolomics Leiden University Medical Center 2333ZA Leiden The Netherlands; Center for Proteomics and Metabolomics Leiden University Medical Center 2333ZA Leiden The Netherlands; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Centre for Medicines Discovery Nuffield Department of Medicine University of Oxford Oxford OX3 7FZ UK; Centre for Medicines; (Angewandte Chemie. international edition, v.64, 2025, pp.e202420149)
QUICK MENU
